COVID ‐19 vaccination in splenectomized patients with immune thrombocytopenia: Correspondence
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19574 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Hinpetch Daungsupawong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Private Academic Consultant, Phonhong, Lao People's Democratic Republic. Hauptthemen laut MEDLINE: Splenectomy, Purpura, Thrombocytopenic, Idiopathic, COVID-19, COVID-19 Vaccines. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Private Academic Consultant, Phonhong, Lao People's Democratic Republic.
- Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
ORCID-Profile: Hinpetch Daungsupawong
Zitieren
APA
Daungsupawong, H., & Wiwanitkit, V. (2024). COVID ‐19 vaccination in splenectomized patients with immune thrombocytopenia: Correspondence. British Journal of Haematology. https://doi.org/10.1111/bjh.19574
Vancouver
Daungsupawong H, Wiwanitkit V. COVID ‐19 vaccination in splenectomized patients with immune thrombocytopenia: Correspondence. British Journal of Haematology. 2024. doi:10.1111/bjh.19574
BibTeX
@article{Daungsupawong2024,
author = {Daungsupawong, Hinpetch and Wiwanitkit, Viroj},
title = {COVID ‐19 vaccination in splenectomized patients with immune thrombocytopenia: Correspondence},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19574}
}
EUVIMED